How to Create a Custom Model Context Protocol (MCP) Client Using Gemini
Source: MarkTechPost In this tutorial, we will be implementing a custom Model Context Protocol (MCP) Client using Gemini....
UniME: A Two-Stage Framework for Enhancing Multimodal Representation Learning with MLLMs
Source: MarkTechPost The CLIP framework has become foundational in multimodal representation learning, particularly for tasks such as image-text...
Syntiant CEO Kurt Busch Receives Silver Stevie Award for ‘Technology Executive of the Year’
Source: Syntiant | GlobeNewswire Inc. IRVINE, Calif., April 29, 2025 (GLOBE NEWSWIRE) — Syntiant Corp., the recognized leader...
Syntiant CEO Kurt Busch Receives Silver Stevie Award for ‘Technology Executive of the Year’
Source: Syntiant | GlobeNewswire Inc. IRVINE, Calif., April 29, 2025 (GLOBE NEWSWIRE) — Syntiant Corp., the recognized leader...
It’s Not About What AI Can Do for Us, But What We Can Do for AI
Source: Unite.AI Most view artificial intelligence (AI) through a one-way lens. The technology only exists to serve humans...
ThinkPRM: A Generative Process Reward Models for Scalable Reasoning Verification
Source: MarkTechPost Reasoning with LLMs can benefit from utilizing more test compute, which depends on high-quality process reward...
Kieran Norton, Deloitte’s US Cyber AI & Automation leader – Interview Series
Source: Unite.AI Kieran Norton a principal (partner) at Deloitte & Touche LLP, is the US Cyber AI & Automation...
Navigating the Conversational AI Wave: A Playbook for Executives Looking to Stay Ahead
Source: Unite.AI Conversational AI, which enables machines to simulate human dialogue, has emerged as one of the most...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation...